reports
Galapagos NV: 1 director
A director at Galapagos NV bought 251,911 shares at 30.430USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
- Emira Sagaama
- Maissa Keskes
- Margaux van Oerle
- Stephane Houri
BT.A BT GROUP PLC
CA CARREFOUR SA
BVI BUREAU VERITAS SA
BNP BNP PARIBAS SA CLASS A
MC LVMH MOET HENNESSY LOUIS VUITTON SE
DBK DEUTSCHE BANK AG
MTX MTU AERO ENGINES AG
NOKIA NOKIA OYJ
RF EURAZEO SA
ENI ENI S.P.A.
VOW3 VOLKSWAGEN AG PREF
REP REPSOL SA
BKT BANKINTER SA
NEM NEMETSCHEK SE
ELI ELIA GROUP SA/NV
MAP MAPFRE SA
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
CCEP COCA-COLA EUROPEAN PARTNERS PLC
8TRA TRATON SE
DSY DASSAULT SYSTEMES SA
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
SGSN SGS SA
- Emira Sagaama
- Maissa Keskes
- Margaux van Oerle
- Stephane Houri
BT.A BT GROUP PLC
CA CARREFOUR SA
BVI BUREAU VERITAS SA
BNP BNP PARIBAS SA CLASS A
MC LVMH MOET HENNESSY LOUIS VUITTON SE
DBK DEUTSCHE BANK AG
MTX MTU AERO ENGINES AG
NOKIA NOKIA OYJ
RF EURAZEO SA
ENI ENI S.P.A.
VOW3 VOLKSWAGEN AG PREF
REP REPSOL SA
BKT BANKINTER SA
NEM NEMETSCHEK SE
ELI ELIA GROUP SA/NV
MAP MAPFRE SA
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
CCEP COCA-COLA EUROPEAN PARTNERS PLC
8TRA TRATON SE
DSY DASSAULT SYSTEMES SA
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
SGSN SGS SA
- Martin Marandon-Carlhian
- Stephane Houri
- Martin Marandon-Carlhian
- Stephane Houri
- Jacob Mekhael
- Kristof Samoy
Aalberts Key Take-aways 1H25 Analyst Call
This morning Aalberts reported 1H25 numbers. Building continued to show a minimal organic growth in 2Q (as in 4Q and 1Q). In Industry the topline decline slowed down to -2.9% and margins benefitted from footprint and cost out initiatives (+90bps q/q). Semicon suffered from an acceleration in the growth decline to -15.5% (2Q) from -11.3% (1Q). Overall, management no longer banks on a growth recovery in 2H25 and expects full year margins to be at 13-14% (previously > 15%). 2026 margin targets (16-...
- Martijn Den Drijver
- Martin Marandon-Carlhian
- Stephane Houri
- Martial Descoutures
- ING Helpdesk
Benelux Morning Notes
Aalberts: Light 1H performance, lowers FY25 outlook. Acomo: Hot chocolate. BAM Group: Solid 1H25 performance. BE Semiconductor Industries: 2Q25 results, light at the end of the tunnel. Econocom: 1H25 REBITA in line, net profit hit by €18m loss on discontinued. Orange Belgium: Better 1H25, guidance increased but MSA hurt perception. RELX: 1H25 results – powering ahead. UCB: 1H25 Preview: focus on US expansion.
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Thibault Leneeuw
- Wim Lewi
- Jacob Mekhael
Galapagos Uneventful 1H25 results, updates to come with 3Q25 results
Galapagos reported uneventful 1H25 results with € 3.1b in cash, though no FY25 cash burn guidance was provided (previously € 175-225m) and an update is expected with the 3Q25 results. In the pipeline, strategic alternatives continue to be explored for the cell therapy business and more information is expected with the 3Q25 results. € 37 TP maintained, though we update our rating to Accumulate (from Buy) given the absence of near-term triggers.
- Martial Descoutures
- Pierre FerraguÊ
- Rolf Bulk
Aalberts N.V.: Aalberts reports first half-year results 2025
Aalberts N.V.: Aalberts reports first half-year results 2025 Utrecht, 24 July 2025 highlights(before exceptionals) revenue EUR 1,557 millionorganic revenue decline 3.2%EBITA EUR 210 million; EBITA margin 13.5%earnings per share before amortisation EUR 1.38free cash flow EUR 56 million CEO statement“Our performance for the first half of the year has been impacted by the continued softness of our end markets, mostly automotive and semicon, and increased uncertainties due to global trade policies, leading to an organic revenue decline in our industry and semicon segments. We sustained our...
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executiv...
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation Appoints Sooin Kwon as Chief Business Officer and Dan Grossman as Chief Strategy Officer Both executives possess proven track records in strategic execution and deal-making and will help drive long-term value creation at Galapagos Mechelen, Belgium; July 23, 2025, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointments of Ms. Sooin Kwon as Chief Business Officer (CBO) and Mr. Dan Grossman as Chief Strategy Officer (CStO), effective August 4, 2025, furth...
Galapagos versterkt managementteam met ervaren life sciences leidingge...
Galapagos versterkt managementteam met ervaren life sciences leidinggevenden om bedrijfstransformatie te versnellen Benoemt Sooin Kwon tot Chief Business Officer en Dan Grossman tot Chief Strategy Officer Beide leidinggevenden hebben een bewezen staat van dienst op het gebied van strategische uitvoering en het sluiten van deals en zullen helpen bij het stimuleren van waardecreatie op lange termijn bij Galapagos Mechelen, België; 23 juli, 2025, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) kondigde vandaag de benoemingen aan van mevrouw Sooin Kwon als Chief Business Officer (CBO) e...
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos an...
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors New Directors bring deep commercial, operational, and transaction experience to the Board Mechelen, Belgium; July 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointments by way of co-optation of Dawn Svoronos and Jane Griffiths as Non-Executive Independent Directors to its Board of Directors, effective July 28, 2025. Dawn Svoronos and Jane Griffiths will replace Peter Guenter and Simon Sturge, who will step down from the Board on July 28, 20...
Galapagos verwelkomt ervaren farmaceutische leidinggevenden Dawn Svoro...
Galapagos verwelkomt ervaren farmaceutische leidinggevenden Dawn Svoronos en Jane Griffiths in haar Raad van Bestuur Nieuwe Bestuurders brengen uitgebreide commerciële, operationele en transactionele ervaring mee naar de Raad van Bestuur Mechelen, België; 23 juli 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) kondigde vandaag de benoeming aan, via coöptatie, van Dawn Svoronos en Jane Griffiths, als Niet-Uitvoerende Onafhankelijke Bestuurders van de Raad van Bestuur, met ingang van 28 juli 2025. Dawn Svoronos en Jane Griffiths zullen Peter Guenter en Simon Sturge vervangen, die op...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.